Task: Answer Verification
Input (English): Question: Is sofosbuvir and ribavirin for 6 weeks effective among people with recent hepatitis C virus infection : The DARE-C II study?
Answer: Six weeks of sofosbuvir and ribavirin was safe and well tolerated, but efficacy was suboptimal; further research is needed to determine whether more potent interferon-free direct-acting antiviral regimens will allow treatment duration to be shortened in recent, predominantly asymptomatic HCV infection. (Hepatology 2016;64:1911-1921).
Output (English): no